Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/20/2012US20120238487 Polymer composition useful as a pharmaceutical carrier
09/20/2012US20120237666 Preformulation for Tabletting Natural Mixtures of Conjugated Estrogens
09/20/2012US20120237629 In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives
09/20/2012US20120237627 Pharmaceutical composition for treating cutaneous burns
09/20/2012US20120237624 Vigna unguiculata seed extract and compositions containing same
09/20/2012US20120237620 Hot Flash Relief Compositions and Methods
09/20/2012US20120237615 Pharmaceutical compositions of o-nitro compounds
09/20/2012US20120237614 Peptide able to disrupt the protein complex between the his273 mutaded p53 protein and the oncosuppressive p73 protein in tumor cells and therapeutic uses thereof
09/20/2012US20120237610 Injectable compositions for intra-articular use combining a viscosupplementation agent and a fibroblast growth medium
09/20/2012US20120237605 Multifunctional Metal Nanoparticles Having A Polydopamine-Based Surface and Methods of Making and Using the Same
09/20/2012US20120237604 Stable fat-soluble active principle particles
09/20/2012US20120237603 Abuse-resistant opioid dosage form
09/20/2012US20120237601 Pharmaceutical Compositions Comprising Mycophenolic Acid or Mycophenolate Salt
09/20/2012US20120237600 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents
09/20/2012US20120237599 Enterically coated cysteamine, cystamine and derivatives thereof
09/20/2012US20120237598 Anti-constipation composition
09/20/2012US20120237596 Nutrient delivery drug composition
09/20/2012US20120237595 Methods for treating amyloidosis using 4-(amino)-2-(2,6-dioxo(3-piperidyl))- isoindoline-1,3-dione
09/20/2012US20120237594 Methods of treating hypertriglyceridemia
09/20/2012US20120237592 Endoplasmic reticulum targeting liposomes
09/20/2012US20120237591 Modified drugs for use in liposomal nanoparticles
09/20/2012US20120237590 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012US20120237589 Amphoteric liposomes comprising imino lipids
09/20/2012US20120237585 Adhesive Composition For Carrying Therapeutic Agents As Delivery Vehicle On Coatings Applied To Vascular Grafts
09/20/2012US20120237574 Delayed-release formulation for reducing the frequency of urination and method of use thereof
09/20/2012US20120237573 Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
09/20/2012US20120237572 Antiviral composition comprising a sulfated polysaccharide
09/20/2012US20120237571 Sustained release compositions of alfuzosin
09/20/2012US20120237570 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
09/20/2012US20120237567 Modulating lymphatic function
09/20/2012US20120237566 Inhibiting stomach-acid release, reducing inflammation and preventing and treating cancer: compositions and methods of use
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237564 Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary Disease
09/20/2012US20120237563 Controlled-release formulations of anabaseine compounds and uses thereof
09/20/2012US20120237561 injectable formulations containing asenapine and method of treatment using same
09/20/2012US20120237559 Formulations and methods for treating rhinosinusitis
09/20/2012US20120237556 Topical base and active agent-containing compositions, and methods for improving and treating skin
09/20/2012US20120237551 Immune response modifier formulations containing oleic acid and methods
09/20/2012US20120237550 Maintaining Antibody-Binding Activity Of Immunosuppressant Drug Conjugates
09/20/2012US20120237537 Methods for producing an immune response to tuberculosis
09/20/2012US20120237531 Topoisomerase inhibitors
09/20/2012US20120237508 Fused amino pyridine as hsp90 inhibitors
09/20/2012US20120237504 Compositions and methods for treating inflammation and fibrosis
09/20/2012US20120237503 Screening Method and Therapy with Agonists of DDAH I
09/20/2012US20120237502 Method for treating breast cancer and ovarian cancer
09/20/2012US20120237499 Modulators of TDP-43 Mediated Toxicity and Methods of Use Thereof for Identifying Agents Having Efficacy for the Treatment and Prevention of Proteinopathies
09/20/2012US20120237493 Nucleic acids encoding a mut-t domain-containing polypeptide
09/20/2012US20120237492 Treatment of submental fat
09/20/2012US20120237480 2'allene-substituted nucleoside derivatives
09/20/2012US20120237478 Modulators of pharmacokinetic properties of therapeutics
09/20/2012US20120237477 Methods and compositions for treating post-myocardial infarction damage
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237474 Fluorinated diaryl urea derivatives
09/20/2012US20120237471 Poly(CPP-SA) Anhydride As A Reactive Barrier Matrix Against Percutaneous Absorption Of Toxic Chemicals
09/20/2012US20120237470 Amido-amine polymer compositions
09/20/2012US20120237461 Skin compositions and methods of use thereof
09/20/2012US20120237457 Anti-bacterial oral care composition and method for producing the same
09/20/2012US20120237449 Methods for treating neural cell swelling
09/20/2012US20120237448 Sphingosine kinase type 1 inhibitors, and processes for using same
09/20/2012US20120237446 Compounds for binding and imaging amyloid plaques and their use
09/20/2012US20120237443 Functionalizing implantable devices with a poly (diol citrate) polymer
09/20/2012US20120234721 Diuretic and diuretic-like compound analogs
09/20/2012US20120234316 Isoxazolidine derivatives
09/20/2012DE112010004110T5 Neue parasitentherapie New parasite therapy
09/20/2012CA2850081A1 Isoxazolidine derivatives
09/20/2012CA2835617A1 Benzodioxane inhibitors of leukotriene production
09/20/2012CA2830503A1 Method for making pluripotent stem cells
09/20/2012CA2830474A1 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012CA2830240A1 Methods of treating breast cancer with anthracycline therapy
09/20/2012CA2830234A1 Nuclear hormone receptor modulators
09/20/2012CA2830216A1 Compositions and methods for the treatment of musculoskeletal related diseases and disorders using metal ion-citrate analog complexes
09/20/2012CA2830195A1 Combination of anti-clusterin oligonucleotide with hsp90 inhibitor for the treatment of prostate cancer
09/20/2012CA2830191A1 Combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer
09/20/2012CA2830165A1 Method for treating neurotrauma
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2830143A1 Pyrrolopyridineamino derivatives as mps1 inhibitors
09/20/2012CA2830131A1 Imidazo pyrazines
09/20/2012CA2830126A1 Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes
09/20/2012CA2830115A1 New azaspirodecanone compounds
09/20/2012CA2830043A1 Novel phenylpyridine derivative and drug containing same
09/20/2012CA2829998A1 Substituted diphenyl derivatives
09/20/2012CA2829993A1 Antimicrobial agents
09/20/2012CA2829982A1 Isoxazolidine derivatives
09/20/2012CA2829968A1 Compositions and methods for the therapy and diagnosis of influenza
09/20/2012CA2829947A1 Dosing regimens for the treatment of fabry disease
09/20/2012CA2829939A1 Tricyclic gyrase inhibitors
09/20/2012CA2829832A1 Use of a sprayable composition comprising ambroxol
09/20/2012CA2829825A1 Colonoscopy - preparation
09/20/2012CA2829803A1 Morpholine-spirocyclic piperidine amides as modulators of ion channels
09/20/2012CA2829785A1 Enantiomers of fluconazole analogues containing thieno-[2,3-d]pyrimidin-4(3h)-one moiety as antifungal agents
09/20/2012CA2829770A1 Denture adhesive remover for intraoral and extraoral use
09/20/2012CA2829746A1 Azole derivative
09/20/2012CA2829593A1 Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases
09/20/2012CA2829592A1 Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
09/20/2012CA2829570A1 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/20/2012CA2829164A1 An ophthalmic composition
09/20/2012CA2829101A1 Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
09/20/2012CA2829096A1 Combination therapies for hematologic malignancies
09/20/2012CA2829088A1 Piperazinedione compounds
09/20/2012CA2828622A1 Vaccine formulation of mannose coated peptide particles
1 ... 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 ... 7860